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CHAPTER 5
Phosphorylation of p65 at serine 467 is essential 
for proper transactivation of a subset of
NF-κB target genes
Tobias Wijshake, Nicolette Huijkman, Henk van der Molen, 
Daphne Dekker, Niels Kloosterhuis, Darren Baker, 
Marten Hofker, Jan van Deursen, Lienhard Schmitz &




NF-κB is a key component of the inflammatory response, and constitutive NF-κB activation 
has been implicated in the development and progression of various disorders, including 
atherosclerosis, type 2 diabetes and cancer. Although, activation of the NF-κB pathway is well 
characterized, the exact mechanism by which nuclear NF-κB activity is accurately regulated 
remains ill defined. Recent studies have implicated an essential role for post-translational 
modifications of the activating subunit NF-κB p65 in the gene-specific activation and/
or termination of transcription. To investigate the contribution of phosphorylation of p65 
at serine 467 in murine NF-κB activity at the organismal level, we generated two knock-
in mouse models carrying a mutation at residue 467 of p65. We replaced serine 467 with 
either an alanine or an aspartic acid, leading to non-phosphorylatable (S467A) or phospho-
mimetic (S467D) mice, respectively. Here we report that homozygous S467A mice show 
diminished TNFα-induced expression of pro-inflammatory cytokines, while the expression 
of anti-apoptotic genes was not affected in vivo. This gene-specific regulation was confirmed 
in p65S467A/S467A mouse embryonic fibroblasts (MEFs). In contrast, mutation of serine 467 
into aspartic acid results in increased transactivation of Vcam1 and Icam1 in MEFs. Taken 
together, these data demonstrate that phosphorylation of p65 at serine 467 is essential for 
selective induction of gene expression.
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INTRODUCTION
The transcription factor NF-κB plays a critical role in the regulation of a vast amount of 
genes, including inflammatory cytokines, cell adhesion molecules and anti-apoptotic genes. 
Hereby NF-κB controls many biological processes, such as inflammation, cell survival, 
proliferation and differentiation [1,2]. In an inactive state, NF-κB associates with inhibitory 
IκB proteins, which results in the sequestration of these complexes in the cytoplasm [1]. 
NF-κB activation via the canonical pathway is facilitated by the upstream IκB kinase (IKK), 
which consists of two catalytically active kinases, IKKα and IKKβ, and a regulator subunit 
known as NF-κB essential modulator (NEMO) [1]. Upon stimulation, the activated IKK 
complex phosphorylates IκBα at two N-terminal serine residues. Phosphorylated IκBα is 
subsequently polyubiquitinated and undergoes proteasomal degradation, which enables the 
translocation of canonical NF-κB subunits p65 and p50 to the nucleus, where it can bind to 
cognate κB-sequences and activate transcription of numerous genes [2,3]. 
 Sustained NF-κB activity has been implicated in a large variety of diseases, 
including inflammatory, metabolic, and immunological disorders, cancer, aging, and age-
related diseases [4-7], indicating the necessity of specific and accurate termination of NF-
κB-mediated transcription. Recent studies have demonstrated that the NF-κB transactivating 
subunit p65 undergoes multiple post-translational modifications, including phosphorylation, 
acetylation, methylation and ubiquitination, that are essential for the intensity and duration of 
nuclear NF-κB activity and the control of the exact transcriptional output [8,9]. These post-
translational modifications can occur at multiple sites of p65, and numerous phosphorylation 
sites have been implicated in either increased or decreased NF-κB-mediated transcription 
depending on the stimulus, the phosphorylation site and the target genes [8].
 Phosphorylation of p65 at serine 276 increases NF-κB transcriptional activity 
in response to various stimuli, probably through a conformational change that results in 
enhanced or decreased binding of co-factors [8,10,11]. Knock-in mice in which serine 276 
was replaced by an aspartic acid (S276D) showed a progressive, systemic hyperinflammatory 
condition resulting in severe runting and eventually death between postnatal days 8-20 [12]. 
In contrast, knock-in embryos expressing a p65 mutant carrying an alanine instead of a 
serine at position 276 (S276A) die at different embryonic days due to a number of variegated 
developmental anomalies, which were caused by epigenetic repression [13]. Along this line, 
phosphorylation at threonine 505 was demonstrated to be a negative regulator of various 
biological processes, including apoptosis, autophagy, proliferation, and migration in vitro 
[14].
  Phosphorylation of p65 at serine 468 is mediated by various kinases such as 
glycogen synthase kinase 3 beta (GSK-3β), IKKβ, and IKKε [15-17]. It has been demonstrated 
that phosphorylation of p65 at serine 468 contributes to the selective termination of NF-
κB dependent gene expression [18]. TNF-induced phosphorylation of p65 serine 468 is 
essential for the binding of an ubiquitin ligase complex, which includes the components 
COMMD1 and cullin 2. This multimeric ubiquitin ligase complex mediates ubiquitination 
and proteasomal-dependent removal of chromatin-bound p65 at promoter sites of a subset of 
NF-κB genes [18,19]. Analysis of NF-κB target gene expression in MEFs expressing a non-
phosphorylatable form of p65 (S468A) confirmed that regulation of transcription at serine 
468 is highly target gene-specific [16,18,20]. However, genetic evidence that assesses the 
importance of phosphorylation at p65 serine 468 at the molecular, cellular and organismal 
level is still lacking. To address this, we generated two knock-in mouse models expressing a 
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p65 serine 467 mutant (corresponding to human p65 serine 468). We substituted serine 467 
with either an alanine or an aspartic acid, resulting in p65S467A (“non-phosphorylatable”) or 
p65S467D (“phospho-mimetic”) mice, respectively. We demonstrated that mice expressing the 
p65 S467A mutant have impaired TNFα-induced transactivation of pro-inflammatory genes. 
In addition, MEFs derived from p65S467A/S467A mice have diminished total p65 protein levels, 
showed impaired TNF-induced expression of NF-κB-mediated genes, and decreased cell 
viability. In contrast to previous in vitro studies, here we demonstrate that phosphorylation of 
murine p65 at serine 467 is crucial for the transactivation of a subset of NF-κB target genes.
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RESULTS
Generation of p65 S467A knock-in mice
To assess the biological importance of phosphorylation at p65 serine 467 (corresponding to 
human p65 serine 468), we generated a knock-in mouse in which serine 467 is substituted by 
an alanine (“non-phosphorylatable”). Using homologous recombination in embryonic stem 
(ES) cells, we replaced the thymine with a guanine in the murine p65 gene at position c.1399, 
resulting in the substitution of alanine for serine (S467A) (Figure 1A). We obtained chimeric 
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Figure 1. Serine to alanine substitution at residue 467 of p65. (A) Gene targeting strategy to generate p65S467A/
S467A mice. Indicated are the genomic mouse p65 locus spanning exon 8-11 of p65 and exon 1-2 of Sipa1 (top); the 
targeting vector with the T>G substitution in exon 11 (red), loxP sites (black boxes); the p65 S467A locus after 
targeted recombination and crossing with Hprt-Cre recombinase mice to remove the NEO cassette and produce 
p65+/S467A mice. (B) Southern blot of XbaI digested genomic DNA from two ES cell clones and probed with DNA 
fragment showing the 8.2 kb and 5.6 kb fragments representing the wild-type and p65NEO;S467A allele, respectively. 
(C) PCR genotyping of DNA extracted from the tails of two wild-type, two p65+/S467A and two p65S467A/S467A mice. 
(D) Sequencing of p65 cDNA obtained by RT-PCR from livers of wild-type and p65S467A/S467A mice. (E) Genotype 
analysis of offspring derived from breeding S467A heterozygous parents. The expected Mendelian frequency is 
indicated at the bottom.
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chimeras successfully transmitted the mutated p65 allele (referred to as p65NEO;S467A) to their 
offspring (Figure 1B). p65+/NEO;S467A mice were crossed with Hprt-Cre transgenic mice [21] to 
excise the NEO gene cassette (Figure 1A). Genotyping of genomic DNA from pups derived 
from breeding of heterozygous p65+/S467A mice resulted in the generation of p65S467A/S467A mice 
(Figure 1C). Sequencing the p65 cDNA of wild-type and p65S467A/S467A mice confirmed the 
replacement of thymine into a guanine at position c.1399 (Figure 1D). Homozygous knock-
in (p65S467A/S467A) mice were obtained at the expected Mendelian frequency and were overtly 
indistinguishable from control littermates in their first year of life (Figure 1E).
S467A mutation results in reduced p65 protein levels
To address the role of p65 phosphorylation at serine 467 in regulating NF-κB-mediated 
transcription, we cultured MEFs from wild-type and p65S467A/S467A littermates derived from 
13.5 dpc embryos. Western blot analysis of wild-type and homozygous knock-in fibroblast 
lysates demonstrated that p65S467A/S467A MEFs have a significantly reduced amount of p65 
protein. Quantitation of p65 signal revealed that homozygous knock-in fibroblasts have 
p65 protein levels of ~30% compared to p65+/+ MEFs (Figure 2A). To assess whether this 
reduction is due to decreased transcription of the mutated p65 allele, we determined the p65 
mRNA levels in both wild-type and p65S467A/S467A MEFs by qRT-PCR. Levels of p65 mRNA 
was unaltered in homozygous knock-in fibroblasts compared to wild-type cells, indicating 
that the reduced p65 protein level was not caused by impaired gene transcription (Figure 2A). 
Western blot analysis of various tissue homogenates showed a clear reduction in p65 protein 
levels in lung and gastrocnemius muscle of p65S467A/S467A mice compared to wild-type controls 
(Supplemental Figure 1). The difference in the p65 protein was less clear in liver, kidney and 
heart tissue of wild-type and p65S467A/S467A mice, but is still trending towards a reduction in 
homozygous knock-in mice (Supplemental Figure 1). A possible explanation for the reduced 
p65 protein levels might be that the mutated p65 protein results in conformational changes 
which makes the protein unstable and subject to rapid proteasomal degradation [22].
Figure 2. Characterization of 
p65 S467A mutant MEFs. (A) 
Immunoblot analysis of p65 protein 
levels in wild-type and S467A MEFs 
generated from embryos at 13.5 dpc. 
Actin was used as a loading control 
(left). Quantitation of relative p65 
protein amount in 3 independent wild-
type and homozygous knock-in MEF 
lines shown on left (middle). Relative 
p65 mRNA expression of wild-type 
and homozygous knock-in MEFs as 
determined by quantitative RT-PCR 
(right). All values represent average ± 
SEM, ** = P < 0.01. (B) Western blot 
analysis of degradation and resynthesis 
of IκBα proteins in whole cell extracts 
of MEFs after TNFα stimulation (10ng/ml). In addition, the levels of phosphorylated p65 at serine 534 in wild-type 
and p65S467A/S467A MEFs are indicated.
 Next, we determined whether the upstream NF-κB activation in S467A MEFs was 
affected. Time course analysis of TNFα-mediated NF-κB activation demonstrated normal 



















































2B). Furthermore, TNFα-mediated phosphorylation of p65 at serine 534 (corresponding to 
human p65 serine 536) showed similar kinetics in both wild-type and p65S467A/S467A MEFs. 
Although, the amount of phosphorylated p65 and total p65 was less in the homozygous 
knock-in fibroblasts (Figure 2B). Altogether, these data demonstrate that mutation of serine 
467 to alanine results in decreased p65 levels in MEFs and in various tissues, but it does not 
affect the upstream activation of the NF-κB pathway.
Absent phosphorylation at serine 467 impairs transactivation of NF-κB-dependent 
genes
Previous studies have demonstrated that phosphorylation of p65 has an essential role in the 
transcriptional output of NF-κB [12,13,16-18,20]. To determine whether the S467A mutation 
affects NF-κB-mediated transcription, we examined the inducible expression of a number 
of well-known NF-κB target genes. We stimulated both wild-type and p65S467A/S467A MEFs 
with TNFα and monitored the expression kinetics of these genes by qRT-PCR. Homozygous 
knock-in MEFs showed impaired transactivation of various pro-inflammatory cytokines, 
including Tnfα, Il-1α, and Mcp-1 (Figure 3A). In addition, the gene expression of two cell 
adhesion molecules, namely Icam1 and Vcam1 was markedly reduced in S467A mutant 










































































































































Figure 3. Impaired activation of NF-κB-mediated gene expression. (A) Relative mRNA expression of pro-
inflammatory cytokines, NF-κB target genes and anti-apoptotic genes at 0, 1,5 and 8 hours after TNFα stimulation 
(10ng/ml). Values represent 6 independent wild-type and S467A MEF lines. (B) Cell viability was assessed in wild-
type and S467A MEFs after 24-hours exposure to various amounts of TNFα. We used 3 independent MEF lines. All 
values represent average ± SEM, * = P < 0.05, ** = P < 0.01, and *** = P < 0.001.
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impaired in homozygous knock-in fibroblasts (Figure 3A). In contrast, expression of several 
additional NF-κB target genes, such as IκBα, Il-6 and A20 were not markedly changed in 
p65S467A/S467A MEFs (Supplemental Figure 2). Taken together, the above data demonstrate that 
loss of phosphorylation at serine 467 impairs the transactivation of a subset of NF-κB target 
genes.
 As substitution of serine 467 by an alanine impaired the transactivation of various 
anti-apoptotic genes (Figure 3A), we decided to examine if homozygous S467A MEFs are 
sensitive to TNFα-induced cell death. Cell viability assays in which we exposed MEFs to 
various concentrations of TNFα resulted in reduced cell viability in mutant S467A MEFs, 
while wild-type MEFs were unaffected (Figure 3B). 
 To investigate whether the impaired activation of NF-κB target genes and reduced 
cell viability in p65S467A/S467A MEFs is due to reduced p65 protein levels, we repeated 
these analyses in p65+/- MEFs. Western blot analysis in p65+/-, p65-/- and p65S467A/S467A cells 
demonstrated that total p65 protein levels were ~55%, 0% and ~30%, respectively of those in 
p65+/+ MEFs (Supplemental Figure 3A). Basal and TNFα-induced expression of several pro-
inflammatory, anti-apoptotic and other NF-κB target genes showed a two-fold reduction in 
p65+/- MEFs compared to control cells (Supplemental Figure 3B). This suggests that reduced 
p65 protein levels in p65S467A/S467A MEFs can not completely account for the differential 
impairment in TNFα-induced NF-κB transactivation (Figure 3 and Supplemental Figure 2). 
Next, we repeated the cell viability assay and similar to our previous experiment (Figure 3B), 
homozygous knock-in cells showed a significant reduction in cell viability (Supplemental 
Figure 3C). Despite the reduced expression of anti-apoptotic genes, p65 haplo-insufficient 
MEFs demonstrated no increased sensitivity to TNF-induced cell death compared to wild-
type controls (Supplemental Figure 3B-C). Taken together, these data suggest that diminished 
p65 protein levels in p65S467A/S467A MEFs cannot completely explain the observed differences 
in TNFα-induced NF-κB transactivation and cell viability.
Gene-specific regulation of NF-κB target genes in S467A mutant mice
Genetic inactivation of hepatic p65 sensitizes mice to lethal liver injury upon TNF 
administration. In depth analysis demonstrated a huge increase in transaminase levels and 
liver apoptosis in liver-specific p65 knockout mice [23]. This combined with the observed 
TNFα-induced cell death in the S467A MEFs, prompted us to test whether p65S467A/S467A 
mice are sensitive to liver induced injury upon TNFα administration. However, examination 
of transaminase concentrations at 12 hours after orbital TNFα injection (15μg/kg) showed 
no detectable enhancement of ALT/AST plasma levels in both wild-type and homozygous 
knock-in mice, indicating that p65S467A/S467A mice have no increased sensitivity to TNFα-
induced liver injury (data not shown).
 Next, we evaluated whether the S467A mutation affects the activation of NF-κB 
in vivo. Wild-type and S467A mutant mice received an injection with either PBS or TNFα 
(15μg/kg) and the expression of various NF-κB genes by qRT-PCR was examined. Analysis 
of a number of tissues at 1 hour post injection revealed that Icam1 expression was markedly 
reduced in liver, kidney, heart, lung and gastrocnemius muscle of p65S467A/S467A mice (Figure 
4). Furthermore, the induced expression of inflammatory cytokines, including Mcp1, Tnfα, 
and Il-6 was impaired in most tissues of S467A mutant mice (Figure 4). In contrast, activation 
of anti-apoptotic gene expression was not affected in p65S467A/S467A mice (Supplemental Figure 
4), indicating that serine 467 of p65 is implicated in the gene-specific regulation of NF-κB 
target genes in vivo.
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Figure 4. Gene-specific regulation of inflammation. Expression of pro-inflammatory and NF-κB target genes was 
assessed in various tissues at 1 hour after orbita injection with either PBS or TNFα (15μg/kg). PBS, n = 7 male mice 
per genotype; TNFα, n = 6 male mice per genotype. All values represent average ± SEM, * = P < 0.05, ** = P < 0.01, 
and *** = P < 0.001. Gastro = gastrocnemius muscle.
Normal activation of the NF-κB pathway in homozygous S467D mice
To further understand the importance of phosphorylation at p65 serine 467, we decided 
to generate an additional knock-in mouse model in which serine 467 is substituted by an 
aspartic acid (“phospho-mimetic”). A similar targeting strategy was used for the generation 
of the S467D allele (Supplemental Figure 5A). The mutant S467D allele was successfully 
engineered, confirmed by genotyping and sequence analysis (Supplemental Figures 5B-
D). Homozygous S467D mice were obtained at the expected Mendelian frequency and 
looked overtly normal up to one year of age (Supplemental Figure 5E). Characterization of 
wild-type and p65S467D/S467D MEFs demonstrated that p65 protein levels are comparable in 
wild-type and homozygous knock-in cell lysates (Figure 5A). Next, we assessed whether 
the S467D mutation affects the upstream activation of the NF-κB pathway. Time course 
analysis after TNFα stimulation showed normal degradation and resynthesis of IκBα protein 
levels in homozygous knock-in MEFs (Figure 5B). In addition, we studied the kinetics of 
TNFα-induced phosphorylation of p65 at serine 467 and showed in wild-type MEFs that 
phosphorylation of serine 467 is an early event that disappeared after 30 minutes (Figure 
5B). Of notice, the used antibody detected the mutated p65 protein in both unstimulated and 
stimulated S467D cells  (Figure 5B). We observed similar kinetics of TNFα-stimulated p65 


































































































































































































































level of phosphorylated p65 at serine 534 was markedly reduced in homozygous knock-in 
MEFs (Figure 5B).
Increased activation of a subset of NF-κB target genes
To investigate whether the S467D mutation affects NF-κB-mediated gene expression in 
MEFs, we activated the NF-κB pathway and determined the expression of the same set of NF-
κB target genes as we did for the S467A mutant. Except for Icam1 and Vcam1, we observed 
no significant changes in TNFα-induced gene expression (Figure 6 and Supplemental Figure 
6). The levels of Icam1 and Vcam1 mRNA were enhanced in p65S467D/S467D MEFs after 1.5 
hours of stimulation (Figure 6). Altogether, these data suggest that the S467D mutation only 
affects the expression of a very small subset of NF-κB-mediated genes.
Figure 6. Enhanced activation of a subset of NF-κB target genes. Expression of pro-inflammatory cytokines, 
NF-κB target genes, and anti-apoptotic genes was determined by qRT-PCR in wild-type and p65S467D/S467D MEFs after 
TNFα stimulation (10ng/ml) at 0, 1,5 and 8 hours. Values represent 4 independent lines per genotype and represent 


















































































































Figure 5. Characterization of p65 S467D mutant MEFs. (A) Western blot analysis of p65 protein expression 
in wild-type and p65S467D/S467D MEFs. Tubulin was used as a loading control. (B) Immunoblot analysis of the 
degradation and resynthesis of IκBα proteins in whole cell extracts of MEFs after TNFα stimulation (10ng/ml). In 
addition, levels of phosphorylated p65 at serine 467 and serine 534 are shown. Actin was used as a loading control.
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DISCUSSION
Post-translational modifications of the activating subunit of NF-κB p65 are essential in 
determining the duration and strength of nuclear NF-κB activity and its transcriptional output 
[8,9]. Phosphorylation of p65 can occur at various residues and results in either increased 
[10,12,17,24-28] or decreased [14-16,18,19,29-31] transcriptional activity depending on 
the stimuli, the phosphorylation sites and the target genes [8]. Serine 468 phosphorylation 
facilitates the binding of a multimeric ubiquitin ligase complex that mediates the 
ubiquitination and subsequent proteasomal-dependent removal of DNA-bound p65 on a 
subset of NF-κB regulated promoter sites [18,19]. Furthermore, this selective termination 
of transcription was confirmed in serine 468 mutant studies where absent phosphorylation 
resulted in gene-specific activation of NF-κB target genes [18,20]. To study the function of 
this specific phosphorylation site of p65 in more detail, we engineered two knock-in mouse 
models expressing a mutant p65, in which serine 467 is substituted with either an alanine 
(S467A) or an aspartic acid (S467D). We found that homozygous S467A mice have an 
impaired activation of Icam1 and pro-inflammatory gene expression in various tissues upon 
TNFα stimulation, whereas expression of anti-apoptotic genes was unaltered. This suggests 
that phosphorylation at serine 467 of p65 is essential for the gene-specific activation of NF-
κB-mediated expression in vivo. Additional studies are needed to explain the underlying 
mechanisms of this regulation, but one likely explanation would be the effect of the observed 
reduction in p65 protein levels in multiple tissues of p65S467A/S467A mice. Another option is 
that the S467A mutation increases the recruitment histone deacetylases that changes the 
epigenetic environment and leads to repression of a subset of genes, which was demonstrated 
for the S276A mutation [13]. Along this line, ChIP analysis on the Cxcl2 promoter revealed 
enhanced levels of histone acetylation associated with decreased recruitment of histone 
deacetylase 1 in phospho-mimetic p65 T435D mutants [28]. Furthermore, phosphorylation 
at serine 467 of p65 is necessary to induce a conformational change and absence of this 
conformational change might result in different protein-protein interactions [22].
 In addition, we have revealed that homozygous S467A MEFs have lower p65 
protein levels, reduced cell viability, and diminished TNFα-induced expression of various 
inflammatory cytokines, cell adhesion molecules and also anti-apoptotic genes. In contrast, 
p65S467D/S467D MEFs demonstrated an increased TNFα-inducible activation of Icam1 and 
Vcam1, while expression of most NF-κB target genes was unaffected. These results were 
unexpected, as two previous studies in which they examined NF-κB target gene expression 
in p65-/- MEFs reconstituted with either human wild-type p65 or a non-phosphorylatable 
form of p65 (S468A) demonstrated increased expression of Icam1 and Vcam1 in the mutant 
MEFs [18,20]. They showed that mutant p65 protein had an increased stability and prolonged 
occupation on the Icam1 promoter, suggesting that absent phosphorylation in S468A MEFs 
reduces ubiquitin/proteasomal degradation of p65 [18]. In contrast, in our studies we found 
that p65 protein levels were significantly diminished in the homozygous S467A MEFs, 
which was not due to impaired transcription. Possibly, the correction for input of total p65 
protein for the reconstituted MEFs in this previous study may have actually resulted in an 
overexpression of the non-phosphorylatable form of p65. This could potentially explain the 
opposite effect on Icam1 and Vcam1 expression, but not the increased protein stability in 
S468A mutant MEFs [18,20].
 Independent comparison of expression analysis in homozygous S467A and p65+/- 
MEFs excluded the possibility that reduced p65 protein levels alone are sufficient to explain 
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the impaired activation of NF-κB target genes in p65S467A/S467A MEFs. First, the transactivation 
of some NF-κB genes was unaffected in the homozygous S467A MEFs, whereas these are 
impaired in the p65+/- MEFs. Second, the levels of reduction in TNF-induced NF-κB-mediated 
gene expression were larger in p65+/- MEFs.
 In contrast, the increased sensitivity in TNFα-induced cell death in homozygous 
S467A compared to p65+/- MEFs might be due to reduced p65 protein levels. Indirect 
comparison of anti-apoptotic gene expression revealed no differences between both 
genotypes, suggesting that another mechanism is responsible for the elevated cell death in 
the p65S467A/S467A MEFs.  Perhaps, the p65 protein levels in p65S467A/S467A MEFs are below a 
certain threshold that causes increased TNFα-induced cell death, but additional experiments 
are necessary to determine the exact trigger of this reduced cell viability.
 Collectively, our study supports the notion that serine 467 of murine p65 plays a 
critical role in the gene-specific activation of NF-κB-mediated expression in both MEFs 
and mice. Interestingly, in vivo TNF injections in homozygous S467A mice showed reduced 
activation of inflammatory genes, while genes involved in apoptosis were unaffected. 
Therefore, it would be of great interest to further investigate the contribution of phosphorylated 
p65 at serine 467 in the progression of various inflammatory-related diseases.
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MATERIAL AND METHODS
Generation of S467A and S467D mice
The p65S467A allele was produced through recombineering as described before [32]. 
The genomic p65 gene fragment spanning exons 8-11 was retrieved from BAC #bMQ-
331N14 (129S7/SvEv ES Cell, Source BioScience) and transferred into pDTA.4B. Exon 
11 was amplified with the following primers: forward (5’-AAGCTTTATGACCGCAGT-
AGCTAG-3’) and reverse (5’-AAGCTTTAGTGGAAGCCCTGT-CCTAG-3’) and 
cloned into pZero (Invitrogen). Introduction of the S467A and S467D knock-in mutation 
into exon 11 was accomplished by site-directed mutagenesis using the following 
primers: forward (5’-GTTCACAGACCTGGCAGCTGTGGACAACTCAGA-3’) and 
reverse (5’-TCTGAGTTGTCCACAGCTGCCAGGTCTGTGAAC-3’) for S467A; 
forward (5’-GG-AGTGTTCACAGACCTGGCAGACGTCGACAACTCAGAGTTT
CAGCAG-3’) and reverse (5’- CTGCTGAAACTCTGAGTTGTCGACGTCTGCCA
GGTCTGTGAACAC-TCC-’3) for S467D. The mutated exon 11 was amplified with 
the following primers: forward (5‘-GGATCCAGCTTTATGACCGCAGTAGC-3’), 
reverse (5’-GCGGCCG-CTCTAGATAGTGGAAGCCCTGTCCTAG-3’) and cloned 
into NotI- and BamHI-restricted pL452 vector harboring a loxP-neo-loxP cassette. 
Amplification of pL452_Exon11mut with primers containing 60 bp homology to RelA 
(forward: 5’- ACTGAGCCCGTGCTCCATGGTTCATCCTCTTCGCTGGCTTTGCAGC 
TGTAACATGGTGAGAGTACTAACAAAAGCTGGTACCGGGC-3’ and reverse: 
5’-CTCCTGG-AGCAAGAGGGATCTACGTTATGTGAAGGAACCCCACTCCTATT
GAACCTTTTGGCGGCCGCTCTAGATAGTGGAAGC-3’) was performed to enable 
the replacement of wild-type exon 11 by the mutated exon 11 preceding the loxP-neo-
loxP cassette using recombineering [32]. The final PvuI-linearized targeting vector was 
electroporated into TL1 129Sv/E ES cells. After selection with G418 and expansion, 
transfectants were tested by Southern Blotting for the presence of the NEO;S467A or 
NEO;S467D cassette (Figure 1B and Supplementary Figure 5B). Chimeric mice were 
produced by microinjection of two independent ES cell targeted clones into C57BL/6 
blastocysts. Chimeric males were crossed with C57BL/6 females and these chimeras 
successfully transmitted the targeted allele. Subsequently, p65+/NEO;S467A and p65+/NEO;S467D mice 
were crossed with Hprt-Cre recombinase mice to excise the NEO cassette. The following 
primers were used for PCR genotyping on ear DNA of mice used in our studies: forward 
(5’-GCGTGGCTCACAAGAGTGAC-3’) and reverse (5’-ACCACCTGACCCAGCTC-
TAC-3’) for p65+, p65S467A, and p65S467D; forward (5’-GCGTGGCTCACAAGAGT-
GAC-3’) and reverse (5’-GGCTGCTAAAGCGCATGCT-3’) for p65NEO;S467A and 
p65NEO;S467D; forward (5’-GCGGTCTGGCAGTAAAAACTA-TC-3’) and reverse 
(5’-ACGAACCTGGTCGAAATCAGTG-3’) for Cre. The presence of the S467A 
or S467D mutation was confirmed by sequencing of cDNA derived from livers of 
p65+/+ and p65S467A/S467A mice or p65+/+ and p65S467D/S467D mice using either the forward 
(5’-CTGTCTGCACCTGTTCCAAA-3’) or reverse (5’-CTTAGGAGCTGATCTGACTC-3’) 
primer (Figure 1D and Supplemental Figure 5D). All mice were on a mixed 129Sv/E x 
C57BL/6 genetic background and had ad libitum access to food. For in vivo activation of the 
NF-κB pathway, mice were injected with either 15 μg/kg mTNFα (R&D Systems, #410-MT) 
or PBS (control) via the orbital vein and sacrificed at the indicated times. Plasma and various 
tissues were harvested for further analysis. All animal-related studies were reviewed and 
approved by the Animal Care and Use Committee of the University of Groningen.
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Generation and culture of MEFs
We intercrossed p65+/S467A or p65+/S467D mice to derive p65+/+, p65+/S467A, and p65S467A/S467A or 
p65+/+, p65+/S467D, and p65S467D/S467D MEFs, respectively, from individual 13.5-day-old fetuses. 
In short, the uterus was removed from a female that is at day 13.5 of her pregnancy and 
individual embryos were isolated. The embryonic membrane was removed and stored for 
genotyping. The head and abdominal organs were removed and the remaining embryo was 
minced thoroughly using a razor blade. The minced embryo was resuspended in 7 ml of 
trypsin/EDTA and incubated at 37°C/15 min, vortex every 2 min. MEFs were centrifuged 
at 1500rpm/5 min, resuspended in Dulbecco’s modified Eagle’s medium (Gibco, #31966-
021; 10% FBS, Hyclone, #SV30160-03; 1x MEM non-essential amino acids, Gibco, #11140-
035; Gentamycin 10μg/ml, Gibco, # 15710-049; 2-Mercaptoethanol 50μM, Gibco, #31350-
010) and seeded in a T75 flask. Cells were frozen at low passages and we used low passage 
number for the described experiments. For gene expression analyses, 6 independent wild-
type and homozygous knock-in lines were utilized. We seeded 3x105 MEFs per 35-mm dish 
and activated the NF-κB pathway with 10 ng/ml TNFα. Cells were harvested in 1 ml QIAzol 
Lysis Reagent (Qiagen, #79306) at the indicated times.
Cell viability
For the cell viability assay, we used 3 independent wild-type and homozygous knock-in 
immortalized MEF lines. On day 0, 1x105 MEFs per 35-mm dish were seeded for each 
condition. On day 2, normal medium was replaced by medium containing 0, 25, 50, 75 or 100 
ng/ml mTNFα. After 24 hours, cells were harvested with trypsin and counted with Tryptan 
Blue. Relative cell numbers were calculated by setting the number of cells for the condition 
0 ng/ml mTNFα at 100% for each MEF line.
Western blotting
Tissues were homogenized in potassium phosphate buffer (25mM kPi, 500mM EDTA, 1mM 
DTT) supplemented with phosphatase and protease inhibitors and boiled for 10 minutes. An 
amount of 30μg protein was loaded on Tris-HCl Polyacrylamide gel, samples were separated 
using SDS-PAGE and transferred to PVDF membrane (GE Healthcare, #RPN303F). Bands 
were visualized using ChemiDocTM XRS+ System (Bio-Rad Laboratories BV). Blots were 
probed with the following antibodies: rabbit anti-65 (C-20) (Santa Cruz Biotechnology 
Inc., #sc-372), mouse anti-β-Actin (Sigma-Aldrich BV, #A5441), rabbit anti-α-Tubulin 
(Cell Signaling, #2114), mouse anti-IκBα (L35A5) (Cell Signaling, #4814), rabbit anti-
phospho-NF-κB p65 (Ser536) (93H1) (Cell Signaling, #3033), rabbit anti-phospho-NF-κB 
p65 (Ser468) (Cell Signaling, #3039), goat anti-rabbit IgG (H+L)-HRP Conjugate (Bio-
Rad Laboratories BV, #170-6515), goat anti-mouse IgG (H+L)-HRP Conjugate (Bio-Rad 
Laboratories BV, #170-6516).
Quantitative real-time PCR
Murine tissues were homogenized in 1 ml QIAzol Lysis Reagent. Total RNA was isolated by 
chloroform extraction, precipitated with isopropanol, washed with ethanol and RNA pellets 
were dissolved in RNase/DNase-free water. Reverse transcription of 1μg RNA was performed 
using the Transcriptor Universal cDNA Master Kit (Roche, #05893151001) according to the 
protocol provided by the manufacturer. 20 ng cDNA was used for quantitative real-time PCR 
(qRT-PCR) using FastStart Universal SYBR Green Master (Rox) (Roche, #04913914001) 
and 7900HT Fast Real-Time PCR System (Applied Biosystems). The following PCR 
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program was used: 50°C/2 min, 95°C/10 min, 40 cycles of 95°C/15 sec and 60°C/1 min. Data 
was analyzed with the SDS 2.3 software. We used mouse Cyclophilin A as an internal control 
gene. The sequences of the used primers are listed in Supplemental Table 1. 
Statistical analysis
Statistical analysis was performed using Prism (GraphPad Software) and the unpaired 
Student’s t test.
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SUPPLEMENTAL FIGURES
Supplemental Figure 1. Diminished total p65 protein levels in p65S467A/S467A mice. Western blot analysis of p65 
protein levels in various tissues of 3-month-old male wild-type and homozygous knock-in mice. Ponceau S staining 
was used as a loading control. Gastro = gastrocnemius muscle.
Supplemental Figure 2. Transactivation of additional NF-κB target genes was not markedly impaired in 
S467A MEFs. qRT-PCR analysis was used to determine mRNA expression of IκBα, Il6 and A20 at 0, 1,5 and 8 
hours following TNFα stimulation (10ng/ml). We used 6 independent wild-type and S467A MEF lines. All values 

























































Supplemental Figure 3. Haplo-insufficiency of p65 results in compromised NF-κB-mediated transcription. 
(A) Western blot analysis of p65 protein levels in p65+/+, p65+/-, p65-/- and p65S467A/S467A MEFs. (B) Relative mRNA 
expression of NF-κB target genes in wild-type and p65+/- MEFs at 0, 1,5 and 8 hours after TNFα stimulation. (C) Cell 
viability was determined in p65+/+, p65+/-, and homozygous S467A MEFs following 24 hours exposure to various 



















































































































Supplemental Figure 4. Homozygous S467A mice demonstrate normal activation of anti-apoptotic genes. 
Relative mRNA expression of anti-apoptotic genes was assessed by qRT-PCR in various tissues at 1 hour after 
injection with either PBS or TNFα (15μg/kg). PBS, n = 7 male mice per genotype; TNFα, n = 6 male mice per 





























































































































































Supplemental Figure 5. Generation of p65 S467D knock-in mice. (A) Gene targeting strategy to generate p65S467D/
S467D mice. Indicated are the genomic mouse p65 locus spanning exon 8-11 of p65 and exon 1-2 of Sipa1 (top); the 
targeting vector with the S467D mutation in exon 11 (red), loxP sites (black boxes); the p65 S467D locus after 
targeted recombination and crossing with Hprt-Cre recombinase mice to remove the NEO cassette and produce p65+/
S467D mice. (B) Southern blot of XbaI digested genomic DNA from two ES cell clones and probed with DNA fragment 
showing the 8.2 kb and 5.6 kb fragments representing the wild-type and p65NEO;S467D alleles, respectively. (C) PCR 
genotyping of DNA extracted from two wild-type, two p65+/S467D and two p65S467D/S467D mice. (D) Sequencing of p65 
cDNA obtained by RT-PCR from livers of wild-type and p65S467D/S467D mice. (E) Genotype analysis of offspring 












 10 9 8
 10 9 8  MC1-DTA
 1  2
 1  2
  D    L      A    S     V     D
gac ctg gca tct gtg gac
loxP



































A AA AA AG G GG GGC C C C C CT TC




D             L              A           S            V           D           N
467




+/+ +/m m/m Total
Born 86 128 72 286





  D    L      A     D     V     D
gac ctg gca gac gtc gac
  D    L      A     D     V     D
gac ctg gca gac gtc gac
130
Supplemental Figure 6. NF-κB-mediated gene expression is unaffected in p65 S467D MEFs. Expression of the 
NF-κB target genes: IκBα, Il6 and A20 was determined by qRT-PCR at 0, 1,5 and 8 hours after TNFα stimulation 
(10ng/ml). We used 4 independent wild-type and homozygous knock-in MEF lines. All values represent average ± 
SEM.
Supplemental Table 1. qRT-PCR primer sequences.
Gene Forward 5’ -> 3’ Reverse 5’ -> 3’
p65 ACCGCTGCATCCACAGTT GGATGCGCTGACTGATAGC
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